Content
These physiological alterations manifest as anxiety, tremors, marijuana addiction and paranoia in some cannabis users. The endogenous ligands, AEA and 2-AG, are derived from arachidonic acid. 2-AG is mainly located in the brain and is primarily involved in the signaling process. AEA and 2-AG are produced from cell membrane lipids and move to the extracellular space via diffusion, endocytosis, carrier transport, translocation, and possibly heat shock proteins 28.
How soon after cannabis hyperemesis syndrome treatment will I feel better?
The recent body of research recognizes that patients with CHS impose a burden on the healthcare systems. Understanding the pathophysiology of the endocannabinoid system (ECS) remains central in explaining the clinical features and potential drug targets for the treatment of CHS. The frequency and prevalence of CHS change in accordance with the doses of tetrahydrocannabinol and other cannabinoids in various formulations of cannabis. CHS is unique in presentation, because of the cannabis’s biphasic effect as anti-emetic at low doses and pro-emetic at higher doses, and the association with pathological hot water bathing.
Potential Mechanisms Behind CHS
Future work will be needed to provide more detailed content evaluations to further understand cannabinoid hyperemesis syndrome. Public health responses to CHS are hampered by a lack of comprehensive data and research. The rapid expansion of cannabis legalization has outpaced the research into its health impacts, particularly regarding conditions like CHS. There is a clear need for more robust studies to assess the prevalence, demographics, and long-term outcomes of CHS in a variety of populations. This includes not only observational studies but also randomized controlled trials to assess potential treatment options for CHS.
- CHS causes you to have repeated episodes of vomiting, severe nausea, stomach pain, and dehydration.
- But too many of them may increase your risk for dehydration due to sweating.
- As cannabis becomes more potent and widely available, CHS is increasingly prevalent.
- Lipolysis from elevated ACTH triggers the release of THC from fat cells.
- Cannabidiol (CBD), another major cannabinoid, has gained attention for its potential therapeutic properties, including anti-inflammatory, anxiolytic, and neuroprotective effects 1.
- While marijuana seems to bring on nausea in the stomach, in the brain it usually has opposite effect.
Health News
This trust also encourages patients to accept a CHS diagnosis, preventing them from seeking unnecessary medical consultations and receiving inappropriate treatments. Scopolamine patches are an antimuscarinic agent with an anti-emetic effect for up to three days, ensuring consistent absorption between oral and parenteral medications. Scopolamine is commonly used to alleviate nausea and motion sickness. CHS patients with severe vomiting who are unable to retain their oral anti-emetic medications can benefit from a scopolamine patch. Benzodiazepines, such as lorazepam, have proven acute treatment for CHS 65,66. Intravenous lorazepam administered in doses of 1 to 2 mg every 4 to 6 h has shown symptom relief 65,66.
However, certain patterns can help doctors identify CHS more accurately. Here’s how CHS is diagnosed and how it differs from other conditions. By understanding these causes and risk factors, marijuana users can better recognize the signs of CHS and make informed choices about their cannabis use.
Yet, its relationship with appetite and digestion is far more nuanced, offering potential benefits for weight management, digestive comfort, and overall wellness. This complexity arises from the endocannabinoid system (ECS), a network of receptors and signaling molecules that regulates hunger, metabolism, and gut function. Through compounds like THC, CBD, and THCV, along with aromatic terpenes, cannabis can stimulate or suppress appetite, ease nausea, or support a healthy gut microbiome.
- This mechanism implies that the analgesic and sensory effects of TRPV1 receptor activation might contribute to the relief experienced during hot showers for CHS patients.
- However, questions remain about the dosage of cannabis, individual and genetic susceptibility, abstinence period and the inclusion of abdominal pain as a criterion.
- In contrast, motivational interviewing attempts to build motivation in an empathic and non-judgemental environment and emphasize the importance of self-efficacy and positive change.
- Since THC is stored in your body fat, it can take weeks to months before all the symptoms go away and you notice a difference.
- CBG has the potential to reverse the antiemetic effects of CBD, suggesting that CHS could result from the interplay between high levels of CBD and its reversal by CBG 25,26.
- A good patient–physician relationship helps achieve CHS remission sooner and avoids unnecessary diagnostic workups 106.
That may cause the repeated bouts of vomiting found in people with CHS. Understanding what triggers cannabinoid hyperemesis syndrome (CHS) can help those affected make better decisions about their cannabis use. CHS is linked to heavy or long-term cannabis use, and while the exact cause is still being studied, there are several potential mechanisms and risk factors that may lead to this condition. Knowing these can help marijuana users recognize the signs early, seek appropriate https://ecosoberhouse.com/article/heroin-addiction-treatment-full-recovery-is-possible/ treatment, and avoid further complications.
CHS is a newly identified condition, so doctors currently know little about it. No clinical guidelines exist, so they must rely on published case reports to treat people with CHS. Results from these case studies suggest that lorazepam might be an effective drug to control symptoms during the hyperemesis stage. Some people with CHS require pain relievers if abdominal pain is present. People in the hyperemesis stage will experience intense and persistent nausea and vomiting.
What is CHS?
If you suspect you have CHS, it is crucial to consult a marijuana doctor who can evaluate your symptoms and cannabis use history to provide a proper diagnosis and suggest the best treatment plan. Alternative TCAs such as nortriptyline and doxepin may be used when amitriptyline is not tolerated well, owing to its excessive sedative nature in certain patients. Nortriptyline and doxepin have fewer adverse effects and provide substantial therapeutic benefits. Doxepin is generally better tolerated and is started at a dose of 10 mg. The dose can be gradually increased in 10 mg increments every 1–2 weeks until the G.I. Cardiac arrhythmias have not been observed with gradual dose titration.
The modulation of CB1 receptors holds promise but also necessitates further investigation to ensure the safety and well-being of patients undergoing such treatments 44-46. Since the Department of Justice issued a memo that it would not prosecute marijuana users and sellers who complied with state law in 2009, hospital discharges for compulsive vomiting have increased by 8% annually 13. This rise may, in part, be due to recognition bias, as emergency department (ED) physicians fail to recognize cyclic vomiting in more than 80% of cases 14. Both conditions predominantly affect younger individuals, with CHS showing a higher prevalence in males, which aligns with the higher rates of cannabis use among men. While CVS tends to be more common in women according to some studies, gender biases in both conditions remain inconclusive 15.
In this narrative review, we elaborate on the role of the ECS, its management, and the identification of gaps in our current knowledge of CHS to further enhance its understanding in the future. Treatment of CHS typically occurs during the hyperemetic phase, which often requires hospitalization due to the severity of symptoms. In this phase, patients frequently experience intractable nausea and vomiting that is unresponsive to conventional antiemetic medications 33. As noted earlier, hot baths or showers provide temporary relief for many patients.
